July 24, 2012 — Navidea Biopharmaceuticals Inc., a specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced that clinical data from a head-to head study comparing its amyloid imaging candidate, AZD4694, to the benchmark amyloid imaging agent, 11C-PiB (PiB), was presented at the Alzheimer's Association International Conference (AAIC) in Vancouver, Canada by Professor Christopher Rowe, MD, FRACP, Director of the Department of Nuclear Medicine and Centre for PET at Austin Health, Melbourne, Australia.

July 24, 2012 — Carestream launched its new Vita XE CR imaging system, which is now available for order worldwide. The tabletop computed radiography (CR) system produces diagnostic quality images at a speed of 60-plus plates per hour and is an ideal fit for smaller hospitals, imaging centers, clinics and private practices.

July 24, 2012 — M*Modal, a provider of clinical documentation and speech understanding solutions, announced United Hospital System has selected the M*Modal Fluency family of cloud-based solutions to deliver advanced clinical documentation to its health system and physicians.

July 23, 2012 — GE Healthcare announced the final results from a Phase III study of the investigational PET (positron emission tomography) amyloid imaging agent, F-18 flutemetamol, in terminally ill patients who had agreed to undergo postmortem brain autopsy. The data showed strong concordance (sensitivity and specificity) between flutemetamol PET images and beta amyloid brain histopathology.

July 23, 2012 — A recent study published in the American Journal of Roentgenology has reconfirmed that virtual colonoscopy (CT colonography) is an effective screening tool for colorectal cancer in seniors age 65 and older.

July 23, 2012 — The U.S. Food and Drug Administration (FDA) granted Ferring Pharmaceuticals Inc. approval to market Prepopik (sodium picosulfate, magnesium oxide and anhydrous citric acid) for oral solution indicated for cleansing of the colon as a preparation for colonoscopy in adults. Prepopik is a low-volume, orange-flavored, dual acting, stimulant and osmotic laxative.

July 23, 2012 — Accuray Inc. announced it has signed a definitive agreement to acquire Morphormics Inc., a privately held company founded by University of North Carolina at Chapel Hill faculty members based on their research in autosegmentation of medical images.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now